CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 13,422 shares at an average $2.58 ($34,616)
- 4 Open-market buy Chief Business Officer bought 1,900 shares at $2.53 ($4,804)
- 4 Open-market buy Director bought 25,000 shares at $2.53 ($63,188)
- 4 Open-market buy PRESIDENT AND CEO bought 21,000 shares at $2.39 ($50,144)
- 4 Open-market buy Director bought 40,485 shares at $2.21 ($89,278)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 9 · 166 filings